Loading
Latest filing published 18 Sept 2026 for Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp., €9,327. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Our data holds just one disclosure by John Michael Langlands, dated 18 September 2026, reporting an option exercise worth €9,327 in Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. Further filings will be added here. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration